HDAC9 and atherosclerosis: In view of the above data indicating that knockout of HDAC9 inhibits EndMT as well as prior knowledge that EndMT is associated with atherosclerotic plaque burden (11) and an unstable plaque phenotype (12, 13), we investigated to determine whether HDAC9 modulates EndMT in vivo and thereby affects atherosclerosis.